29 August 2025
New Qualified Person Appointment Strengthens Regulatory and Quality Excellence.
We’re delighted to announce the appointment of Wendy Cook as a Qualified Person (QP) to further strengthen our regulatory and...
31 July 2025
Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product
We’re delighted to announce the successful completion of our 1,000th sterile drug product batch, marking a significant milestone in our...
24 June 2025
Symbiosis Expands Global Reach with Key Appointment of Angelika Rublack as Senior Business Development Manager
Symbiosis has appointed Angelika Rublack as Senior Business Development Manager to support its expanding global client base and drive growth...
6 May 2025
Symbiosis Honoured with Prestigious King’s Award for Enterprise in International Trade
We’re extremely proud to announce that Symbiosis has been awarded a 2025 King’s Award for Enterprise in the International Trade...
30 April 2025
Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity
Symbiosis is delighted to announce the successful completion of the latest audit by the UK’s Medicines and Healthcare products Regulatory...
31 March 2025
EcoVadis recognises Symbiosis for its Commitment to Sustainability
Symbiosis Pharmaceutical Services (Symbiosis), a leading Contract Manufacturing Organisation (CMO) based in Stirling, UK and specialising in sterile GMP manufacturing...
3 March 2025
Symbiosis Successfully Completes Gene Therapy Focussed FDA Regulatory Inspection
Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has successfully completed its latest inspection by the US Food and Drug...
3 December 2024
Symbiosis signals strong growth ambitions with two key commercial appointments in the US
We’re delighted to announce the expansion of the Symbiosis Business Development team with the addition of two highly experienced U.S....
10 October 2024
Symbiosis acquires new manufacturing facility in a deal financed with Barclays Corporate Bank PLC
Symbiosis acquires 20,000 sq/ft facility to increase high-tech manufacturing capabilities, financed by £1.2m from Barclays Corporate Bank PLC. The additional...
30 August 2024
Scottish Enterprise celebrates record results for Scottish economy during visit to Symbiosis
Scottish Enterprise celebrates record results for Scottish economy Strongest ever performance on jobs and capital investment Scottish Enterprise delivered a...
21 November 2023
Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment
Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced...
4 July 2022
Symbiosis Announces £1 Million Investment in an Analytical Testing Capability
Symbiosis has today announced a 1 million GBP (1.2 million Euros, 1.3 million USD) investment in its in-house analytical services...